239 related articles for article (PubMed ID: 21824073)
1. A decade of targets and patented drugs for chemotherapy of Chagas disease.
Duschak VG
Recent Pat Antiinfect Drug Discov; 2011 Sep; 6(3):216-59. PubMed ID: 21824073
[TBL] [Abstract][Full Text] [Related]
2. Targets and Patented Drugs for Chemotherapy of Chagas Disease in the Last 15 Years-Period.
Duschak VG
Recent Pat Antiinfect Drug Discov; 2016; 11(2):74-173. PubMed ID: 27784230
[TBL] [Abstract][Full Text] [Related]
3. An insight on targets and patented drugs for chemotherapy of Chagas disease.
Duschak VG; Couto AS
Recent Pat Antiinfect Drug Discov; 2007 Jan; 2(1):19-51. PubMed ID: 18221162
[TBL] [Abstract][Full Text] [Related]
4. Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches.
Urbina JA
Acta Trop; 2010; 115(1-2):55-68. PubMed ID: 19900395
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy of Chagas disease.
Urbina JA
Curr Pharm Des; 2002; 8(4):287-95. PubMed ID: 11860367
[TBL] [Abstract][Full Text] [Related]
6. [The chemotherapy of Chagas disease].
Stoppani AO
Medicina (B Aires); 1999; 59 Suppl 2():147-65. PubMed ID: 10668258
[TBL] [Abstract][Full Text] [Related]
7. Trypanothione Reductase: A Target for the Development of Anti- Trypanosoma cruzi Drugs.
Vázquez K; Paulino M; Salas CO; Zarate-Ramos JJ; Vera B; Rivera G
Mini Rev Med Chem; 2017; 17(11):939-946. PubMed ID: 28302040
[TBL] [Abstract][Full Text] [Related]
8. Clear Shot at Primary Aim: Susceptibility of Trypanosoma cruzi Organelles, Structures and Molecular Targets to Drug Treatment.
Menna-Barreto RF; de Castro SL
Curr Top Med Chem; 2017; 17(10):1212-1234. PubMed ID: 27784255
[TBL] [Abstract][Full Text] [Related]
9. Trypanothione Reductase and Superoxide Dismutase as Current Drug Targets for Trypanosoma cruzi: An Overview of Compounds with Activity against Chagas Disease.
Beltran-Hortelano I; Perez-Silanes S; Galiano S
Curr Med Chem; 2017 May; 24(11):1066-1138. PubMed ID: 28025938
[TBL] [Abstract][Full Text] [Related]
10. Trypanosoma cruzi trypanothione reductase inhibitors: phenothiazines and related compounds modify experimental Chagas' disease evolution.
Rivarola HW; Paglini-Oliva PA
Curr Drug Targets Cardiovasc Haematol Disord; 2002 Jun; 2(1):43-52. PubMed ID: 12769656
[TBL] [Abstract][Full Text] [Related]
11. Ergosterol biosynthesis and drug development for Chagas disease.
Urbina JA
Mem Inst Oswaldo Cruz; 2009 Jul; 104 Suppl 1():311-8. PubMed ID: 19753490
[TBL] [Abstract][Full Text] [Related]
12. First century of Chagas' disease: an overview on novel approaches to nifurtimox and benzonidazole delivery systems.
Salomon CJ
J Pharm Sci; 2012 Mar; 101(3):888-94. PubMed ID: 22161779
[TBL] [Abstract][Full Text] [Related]
13. Major Kinds of Drug Targets in Chagas Disease or American Trypanosomiasis.
Duschak VG
Curr Drug Targets; 2019; 20(11):1203-1216. PubMed ID: 31020939
[TBL] [Abstract][Full Text] [Related]
14. Examination of multiple Trypanosoma cruzi targets in a new drug discovery approach for Chagas disease.
Beltran-Hortelano I; Alcolea V; Font M; Pérez-Silanes S
Bioorg Med Chem; 2022 Mar; 58():116577. PubMed ID: 35189560
[TBL] [Abstract][Full Text] [Related]
15. Trypanosoma cruzi targets for new chemotherapeutic approaches.
Soeiro MN; de Castro SL
Expert Opin Ther Targets; 2009 Jan; 13(1):105-21. PubMed ID: 19063710
[TBL] [Abstract][Full Text] [Related]
16. The chemotherapy of chagas' disease: an overview.
Paulino M; Iribarne F; Dubin M; Aguilera-Morales S; Tapia O; Stoppani AO
Mini Rev Med Chem; 2005 May; 5(5):499-519. PubMed ID: 15892691
[TBL] [Abstract][Full Text] [Related]
17. A cysteine protease inhibitor cures Chagas' disease in an immunodeficient-mouse model of infection.
Doyle PS; Zhou YM; Engel JC; McKerrow JH
Antimicrob Agents Chemother; 2007 Nov; 51(11):3932-9. PubMed ID: 17698625
[TBL] [Abstract][Full Text] [Related]
18. Antitrypanosomal Activity of Sterol 14α-Demethylase (CYP51) Inhibitors VNI and VFV in the Swiss Mouse Models of Chagas Disease Induced by the Trypanosoma cruzi Y Strain.
Guedes-da-Silva FH; Batista DG; Da Silva CF; De Araújo JS; Pavão BP; Simões-Silva MR; Batista MM; Demarque KC; Moreira OC; Britto C; Lepesheva GI; Soeiro MN
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167559
[TBL] [Abstract][Full Text] [Related]
19. Chagas disease: progress and new perspectives.
Sánchez-Sancho F; Campillo NE; Páez JA
Curr Med Chem; 2010; 17(5):423-52. PubMed ID: 20015038
[TBL] [Abstract][Full Text] [Related]
20. Proteomic and bioinformatic analysis of Trypanosoma cruzi chemotherapy and potential drug targets: new pieces for an old puzzle.
Sadok Menna-Barreto RF; Belloze KT; Perales J; Silva FP
Curr Drug Targets; 2014 Mar; 15(3):255-71. PubMed ID: 24041335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]